A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT06949020

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Jemincare (from the registry)
Registry
  • NCT NCT06949020
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06949020. Randomized; triple masking; primary purpose treatment. Start 2025-07-09 (actual); primary completion 2026-03-14 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Dose-finding Study of JMKX003142 in Treatment of Cardiac Edema
Condition
Cardiac Edema
Intervention (Drug)
JMKX003142 Injection
Intervention (Drug)
JMKX003142 Injection
Intervention (Drug)
JMKX003142 Injection
Intervention (Drug)
JMKX003142 placebo
Lead sponsor
Jemincare (class: industry)

Record details

Record id
cardio:ct-nct06949020
Content hash
fd940de9216e43918fa760eb65a07ec7ed1bc060ee902c151b7fb23cdb5f12d6